Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic AMP-responsive element-binding protein 3 (CREB3) is a membrane-bound transcription factor of the endoplasmic reticulum (ER) that belongs to the basic leucine zipper (bZIP) superfamily[3][5]. It is activated by regulated intramembrane proteolysis (RIP) in response to ER or Golgi stress: CREB3 translocates to the Golgi, where cleavage by Site-1 and Site-2 proteases releases its N-terminal fragment, which then enters the nucleus to activate specific genes[2][3][4]. CREB3 family members—including CREB3, CREB3L1, CREB3L2, CREB3L3, and CREB3L4—act as key transcriptional regulators in diverse processes such as the unfolded protein response, metabolism, development, immune signaling, and stress adaptation[2][4]. CREB3 can bind to various DNA motifs, including the cAMP response element (CRE), ER stress response element II (ERSE-II), and the unfolded protein response element (UPRE)[2][3]. It is implicated in disease processes including cancer and neurodegenerative disorders due to its central role in maintaining ER homeostasis and regulating essential cellular responses to stress[2][4][5].
Not applicable directly, as no drugs are known to target CREB3 specifically; in principle, compounds modulating ER stress pathways or transcription factor activity could alter CREB3 function, but no approved mechanisms specific to CREB3 are documented[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic AMP-responsive element-binding protein 3 (CREB3).